Back to FRONTIER CAPITAL MANAGEMENT CO LLC FRONTIER CAPITAL MANAGEMENT CO LLC

BBIOBBIO
Showing 8 of 10 quarters

Position history for FRONTIER CAPITAL MANAGEMENT CO LLCFRONTIER CAPITAL MANAGEMENT CO LLC's holdings in BRIDGEBIO PHARMA INC

FRONTIER CAPITAL MANAGEMENT CO LLC holds 1.4M shares of BBIO (BRIDGEBIO PHARMA INC), worth $102.3M as of 2026-Q2. The position was increased (+43.3% shares). BBIO represents 1.0% of FRONTIER CAPITAL MANAGEMENT CO LLC's portfolio.

Current Value

$102.3M

Current Shares

1.4M

Total Value Change

+$89.5M

Total Shares Change

+869,895

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+43.3%
$102.3M1.0%$74.48
57
2026-Q1
Increased
957,989
+16.0%
$71.1M0.7%$74.26
48
2025-Q4
Increased
826,131
+25.2%
$63.2M0.7%$76.49
51
2025-Q3
Increased
659,633
+23.1%
$34.3M0.3%$51.94
42
2025-Q2
Decreased
535,763
-30.4%
$23.1M0.2%$43.18
0
2025-Q1
Decreased
769,301
-28.5%
$26.6M0.3%$34.57
0
2024-Q4
Increased
1.1M
+113.8%
$29.5M0.3%$27.44
56
2024-Q3
Increased
503,162
+239.1%
$12.8M0.1%$25.46
54

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used